These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 18094727

  • 1. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K, Braam B, Jie KE, Gaillard CA.
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [Abstract] [Full Text] [Related]

  • 2. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS, Wexler D, Iaina A, Schwartz D.
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [Abstract] [Full Text] [Related]

  • 3. Anemia and chronic heart failure implications and treatment options.
    Anand IS.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):501-11. PubMed ID: 18687241
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS, Wexler D, Iaina A.
    J Nephrol; 2004 Aug 12; 17(6):749-61. PubMed ID: 15593047
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
    Silverberg DS, Wexler D, Blum M, Schwartz D, Keren G, Sheps D, Iaina A.
    Isr Med Assoc J; 2003 May 12; 5(5):337-9. PubMed ID: 12811950
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
    Pagourelias ED, Koumaras C, Kakafika AI, Tziomalos K, Zorou PG, Athyros VG, Karagiannis A.
    Angiology; 2009 May 12; 60(1):74-81. PubMed ID: 18413330
    [Abstract] [Full Text] [Related]

  • 15. Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction.
    Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY.
    Int J Cardiol; 2013 Apr 15; 164(3):359-64. PubMed ID: 21821297
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Erythropoietin-- measurement and clinical applications.
    Marsden JT.
    Ann Clin Biochem; 2006 Mar 15; 43(Pt 2):97-104. PubMed ID: 16536911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.